The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Real-life Pan-HER-blockade With Neratinib
Official Title: Neratinib in Patients With HER2+ Breast Cancer: a Multi-centric, Multi-national, Prospective, Longitudinal, Non-interventional Study in Germany, Austria and Switzerland
Study ID: NCT04388384
Brief Summary: So far, there is no data available on treatment of patients with early-stage hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-overexpressed/amplified breast cancer, who completed adjuvant trastuzumab-based therapy less than one year ago, in the clinical routine setting. ELEANOR - designed as a prospective, longitudinal, non-interventional study (NIS) - will investigate real-world use of neratinib and its treatment management in patients with HR-positive, HER2-overexpressing/amplified breast cancer stage I-III having completed adjuvant trastuzumab-based therapy less than one year ago. Data from this study will contribute to a deeper understanding and characterization of the everyday use of neratinib in a broader patient population in the German and Austrian routine setting.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Clinic, Klagenfurt, Kärnten, Austria
Clinic, Vöcklabruck, Oberösterreich, Austria
Clinic, Schwarzach im Pongau, Salzburg, Austria
Clinic, Graz, Steiermark, Austria
Clinic, Salzburg, , Austria
Clinic, Vienna, , Austria
Clinic, Vienna, , Austria
Clinic, Wien, , Austria
Medical Practice, Heidelberg, Baden Wuerttemberg, Germany
Community Health Center, Freiburg, Baden-Wuerttemberg, Germany
Medical Practice, Heidenheim, Baden-Wuerttemberg, Germany
Clinic, Schwäbisch Hall, Baden-Wuerttemberg, Germany
Medical Practice, Villingen-Schwenningen, Baden-Wuerttemberg, Germany
Clinic, Weinheim, Baden-Wuerttemberg, Germany
Clinic, Baden-Baden, Baden-Württemberg, Germany
Clinic, Nürtingen, Baden-Württemberg, Germany
Oncology Center, Offenburg, Baden-Württemberg, Germany
Clinic, Winnenden, Baden-Württemberg, Germany
Medical Practice, Aschaffenburg, Bavaria, Germany
Practice, Augsburg, Bavaria, Germany
Clinic, Deggendorf, Bavaria, Germany
Clinic, Landshut, Bavaria, Germany
Community Health Center, München, Bavaria, Germany
Clinic, München, Bavaria, Germany
Clinic, Ansbach, Bayern, Germany
Clinic, Bamberg, Bayern, Germany
Community Health Center, Eggenfelden, Bayern, Germany
Community Health Center, Landshut, Bayern, Germany
Clinic, Marktredwitz, Bayern, Germany
Medical Practice, Bad Liebenwerda, Brandenburg, Germany
Clinic, Neuruppin, Brandenburg, Germany
Clinic, Potsdam, Brandenburg, Germany
Clinic, Darmstadt, Hessen, Germany
Clinic, Frankfurt, Hessen, Germany
Clinic, Wiesbaden, Hessen, Germany
Community Health Center, Goslar, Lower Saxony, Germany
Practice, Göttingen, Lower Saxony, Germany
Medical Practice, Hildesheim, Lower Saxony, Germany
Medical Practice, Leer, Lower Saxony, Germany
Clinic, Lüneburg, Lower Saxony, Germany
Medical Practice, Westerstede, Lower Saxony, Germany
Medical Practice, Wilhelmshaven, Lower Saxony, Germany
Medical Practice, Greifswald, Meckelnburg-Vorpommern, Germany
Clinic, Rostock, Mecklenburg-Western Pomerania, Germany
Medical Practice, Stralsund, Mecklenburg-Western Pomerania, Germany
Medical Care Center, Georgsmarienhütte, Niedersachsen, Germany
Clinic, Hannover, Niedersachsen, Germany
Clinic, Oldenburg, Niedersachsen, Germany
Medical Practice, Uelzen, Niedersachsen, Germany
Medical Practice, Bonn, Nordrhein-Westfalen, Germany
Medical Practice, Bottrop, Nordrhein-Westfalen, Germany
Clinic, Datteln, Nordrhein-Westfalen, Germany
Clininc, Essen, Nordrhein-Westfalen, Germany
Medical Practice, Gütersloh, Nordrhein-Westfalen, Germany
Clinic, Hamm, Nordrhein-Westfalen, Germany
Clinic, Köln, Nordrhein-Westfalen, Germany
Clinic, Köln, Nordrhein-westfalen, Germany
Medical Practice, Moers, Nordrhein-Westfalen, Germany
Medical Practice, Mülheim/Ruhr, Nordrhein-Westfalen, Germany
Community Health Center, Soest, Nordrhein-Westfalen, Germany
Community Health Center, Neuss, North Rhine-Westphalia, Germany
Medical Practice, Troisdorf, North Rhine-Westphalia, Germany
Clinic, Witten, North Rhine-Westphalia, Germany
Medical Practice, Mayen, Rheinland-Pfalz, Germany
Clinic, Neustadt, Rheinland-Pfalz, Germany
Medical Practice, Burg, Sachsen-Anhalt, Germany
Clinic, Magdeburg, Sachsen-Anhalt, Germany
Clinic, Quedlinburg, Sachsen-Anhalt, Germany
Clinic, Salzwedel, Sachsen-Anhalt, Germany
Clinic, Stendal, Sachsen-Anhalt, Germany
Clinic, Chemnitz, Sachsen, Germany
Oncology Center, Dresden, Sachsen, Germany
Medical Praxis, Freital, Sachsen, Germany
Clinic, Leipzig, Sachsen, Germany
Medical Practice, Plauen, Sachsen, Germany
Medical Practice, Halle Saale, Saxony-Anhalt, Germany
Clinic, Eutin, Schleswig-Holstein, Germany
Medical Care center, Neuwied, Theinland-Pfalz, Germany
Medical Practice, Hildburghausen, Thuringia, Germany
Medical Practice, Erfurt, Thüringen, Germany
Clinic, Jena, Thüringen, Germany
Medical Practice, Meiningen, Thüringen, Germany
Oncology Center, Neuhaus Am Rennweg, Thüringen, Germany
Medical Care Center, Saalfeld, Thüringen, Germany
Clinic, Suhl, Thüringen, Germany
Medical Practice, Suhl, Thüringen, Germany
Medical Practice, Berlin, , Germany
Clinical Practice, Berlin, , Germany
Medical Practice, Berlin, , Germany
Medical Practice, Bremen, , Germany
Clinic, Bremen, , Germany
Oncology Center, Hamburg, , Germany
Practice, Basel, Basel Stadt, Switzerland
Practice, Biel, Bern, Switzerland
Clinic, Chur, Graubünden, Switzerland
Clinic, Olten, Solothurn, Switzerland
Clinic, Lausanne, Vaud, Switzerland
Clinic, Zürich, , Switzerland
Name: Corinne Vannier, Dr
Affiliation: Pierre Fabre Pharma GmbH
Role: STUDY_DIRECTOR